| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |